全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Tulay Kus , Gokmen Aktas ...
来源:[J].Supportive Care in Cancer(IF 2.649), 2017, Vol.25 (11), pp.3347-3355Springer
摘要:Illness perception has been suggested to have a significant effect on anxiety and depression in cancer patients. In this cross-sectional study, we aimed to evaluate this on Turkish breast cancer patients with follow-up periods up to 12 years.
作者:Tulay Kus , Gokmen Aktas ...
来源:[J].Journal of Gastrointestinal Cancer, 2017, Vol.48 (2), pp.170-175Springer
摘要:The aim of this retrospective study was to compare the different treatment options of patients with advanced biliary tract carcinoma (BTC) who were treated with platinum-gemcitabine (CG) or platinum-5-fluorouracil (CF) or 5-Fluorouracil-oxaliplatin-irinotecan (FOLFIRINOX) chemoth...
作者:Tulay Kus , Gokmen Aktas ...
来源:[J].Journal of Cancer Research and Therapeutics(IF 0.761), 2015, Vol.11 (4), pp.974-976DOAJ
摘要:The present case report defines a rare case of a liposarcoma with bone metastasis resulting in a complete remission (CR) following trabectedin treatment. The patient was referred with abdominal swelling and pain. A retroperitoneal mass was detected and described as dedifferentiat...
作者:Tulay Kus , Mehmet Kalender ...
来源:[J].OncoTargets and Therapy(IF 2.073), 2015, Vol.2015 (default), pp.1341-1343Dove
摘要:An epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), erlotinib, is a targeted drug which was approved for the treatment of especially non-small cell lung cancers (NSCLC) and pancreas cancers. Targeted tyrosine kinase inhibitors are known to have a cardiotox...
作者:Tulay Kus , Gokmen Aktas ...
来源:[J].OncoTargets and Therapy(IF 2.073), 2015, Vol.2015 (default), pp.3749-3756Dove
摘要:Purpose: To investigate whether the initial maximum standardized uptake value (SUVmax) on fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) has a prognostic significance in metastatic lung adenocarcinoma exhibiting EGFR-sensitiza...
作者:Tulay Kus , Mustafa Ulaslı ...
来源:[J].OncoTargets and Therapy(IF 2.073), 2016, Vol.2016 (default), pp.5603-5609Dove
摘要:Purpose: The aim of this study is to clarify the relationship between recurrence risk of breast cancer and methylenetetrahydrofolate reductase (MTFHR) C677T polymorphisms.Patients and Method: Operated breast cancer patients followed in Gaziantep University Oncology Hospital ...
作者:Tulay Kus , Taylan Metin ...
来源:[J].OncoTargets and Therapy(IF 2.073), 2018, Vol.2018 (default), pp.1885-1889Dove
摘要:Cancers of unknown primary (CUP) are histologically proven metastatic malignant tumors without identified primary site before treatment. The common characteristics are early dissemination, lower response to chemotherapy and poor prognosis with short life expectancy. Treatment was...
作者:Tulay Kus , Gokmen Aktas ...
来源:[J].Journal of Cancer Research and Therapeutics(IF 0.761), 2015, Vol.11 (4), pp.974-976Wolters Kluwer
摘要:The present case report defines a rare case of a liposarcoma with bone metastasis resulting in a complete remission (CR) following trabectedin treatment. The patient was referred with abdominal swelling and pain. A retroperitoneal mass was detected and described as dedifferentiat...
作者:Tulay Kus , Havva Yesil Cinkir ...
来源:[J].Current Problems in Cancer(IF 1.562), 2019Elsevier
摘要:Abstract(#br)Aim(#br)The positive energy balance and insulin resistance caused by weight gain, physical inactivity, poor dietary quality are linked to a decreased breast cancer (BC)-specific survival. The aim of the present study was to assess whether or not hepatosteatosis,...
作者:Tulay Kus , Gokmen Aktas ...
来源:[J].Supportive Care in Cancer(IF 2.649), 2016, Vol.24 (5), pp.2085-2091Springer
摘要:Abstract(#br) Background(#br)Oxaliplatin and taxane-induced neurosensory toxicity is dose-limiting and mostly presents with acute symptoms that affect the activities of daily living and overall quality of life. The objective of the present study is to assess the relief of ac...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×